Slingshot members are tracking this event:
Celyad(CYAD) initiates Phase 1 SHRINK and LINK trials of CYAD-01 in colorectal cancer patients diagnosed with unresectable liver metastases
Slingshot Insights Explained
May 03, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Shrink, Link, Cyad-01, Colorectal Cancer